Star stocks beat expectations this reporting season

stock doctor webinar
Presented by
Kien Trinh

Kien Trinh

Head of Research

Mathew Potts

Mathew Potts

Member Relationship Manager - Stock Doctor

Sep 10th, 2020
1hr 20mins

The hotly anticipated August reporting season has given us a glimpse of how companies have performed in the midst of an economic contraction. Roughly about 78% of companies have met or beaten market expectations thanks to government support packages and central banks keeping interest rates low.

Reassuringly, our Stock Doctor Star Stocks have performed well, with 84% of our Star Stocks meeting or beating expectations – a reassuring testament to our approach by investing in high quality, financially healthy companies that can weather this challenging COVID-19-induced economic climate. In addition, our quantitative methodology has helped us avoid vulnerable companies that have experienced a radical deterioration in their financial health. Some of these include Qantas Airways (QAN), Webjet (WEB), Star Entertainment Group (SGR) and AMP Limited (AMP).

In this webinar recording, Kien Trinh, Head of Research, and Mathew Potts, Business Development Manager, explain how our Financial Health Model (which is available exclusively through the Stock Doctor platform) has helped our members outperform the market by identifying high quality growth and income opportunities, while managing insolvency risk within their portfolios.

Agenda

  • How Stock Doctor helps you look for growth and income opportunities during reporting season
  • The importance of Financial Health during an economic downturn
  • The methodology behind Lincoln’s portfolio of Star Stocks
  • Using Stock Doctor tools, including the portfolio manager, filters, alerts and corporate calendar to keep you informed during the reporting season
  • Our Managed Fund options including the recently launched Lincoln U.S. Growth Funds
  • Q&A
Presented by
Kien Trinh

Kien Trinh

Head of Research

Mathew Potts

Mathew Potts

Member Relationship Manager - Stock Doctor

Sep 10th, 2020
1hr 20mins
Information in this communication is current as of publication unless otherwise stated. It is provided for educational purposes only and may not reflect current market data or opinion. It should not be relied upon in respect to any current investment decision. Investments can go up and down. Past performance is not a reliable indicator of future performance.

Important: This communication is provided by or on behalf of Lincoln Indicators Pty Limited ABN 23 006 715 573 (Lincoln), as Corporate Authorised Representative of Lincoln Financial Group Pty Ltd ABN 70 609 751 966, AFSL 483167 for information and educational purposes only. This content may contain general financial product advice. It has been prepared without taking account of your personal circumstances and you should therefore consider its appropriateness in light of your objectives, financial situation and needs, before acting on it. Investments can go up and down. Past performance is not a reliable indicator of future performance. Shares and other investments may go up and down in value, and their past performance may not be repeated and gives no guarantee of future performance. Information in this communication was current as at the date of its preparation, unless otherwise stated, and may be subject to change.

You should read and consider our Important Information and our Financial Services Guide (FSG) which sets out key information about the services we provide. Where our advice relates to the acquisition or possible acquisition of a particular financial product, you should obtain a copy of and consider the Lincoln Australian Income Fund Product Disclosure Statement (PDS), Lincoln Australian Growth Fund Product Disclosure Statement (PDS) and Lincoln U.S. Growth Fund Product Disclosure Statement (PDS) for the product at www.lincolnindicators.com.au before making any decision.

At the date of preparation of this communication, Lincoln, Lincoln Financial Group Pty Ltd or directors, employees and/or associates of these entities "may hold" interests in these ASX-listed companies. Further information about particular stocks held by these entities or persons from time to time is disclosed within the Stock Doctor program and may change at any time without notice.

Lincoln, Lincoln Financial Group Pty Ltd, any directors, employees and agents of these entities, make no representation and give no warranty as to the accuracy of this communication and do not accept any responsibility for any errors or inaccuracies in, or omissions from, this communication (whether negligent or otherwise) and are not liable for any loss or damage howsoever arising as a result of any person acting, or refraining from acting, in reliance on any information in this communication. No person should rely on this communication as it does not purport to be comprehensive. This disclaimer does not purport to exclude any rights under, or warranties implied by, law which may not be lawfully excluded.

Lincoln has taken precautions to minimise the risk of transmitting software viruses, but we advise you to carry out your own virus checks on any downloadable content. We do not accept liability for any loss or damage caused by software viruses.

Copyright © 2024 Lincoln Indicators Pty Ltd. All rights reserved.

All financial services are provided by Lincoln Indicators Pty Ltd ABN 23 006 715 573 (Lincoln) as the Corporate Authorised Representative of Lincoln Financial Group Pty Ltd ABN 70 609 751 966, AFSL 483167.

  • Show Popular Searches
  • Lincoln Indicators
  • Managed Funds
  • Investment Funds
  • Mutual Funds
  • Growth Funds
  • High Return Investments
  • Long Term Investments
  • Shares to Invest in Australia
  • Stock Portfolio Manager Software
  • Highest Dividend Stocks ASX
  • Highest Dividend Shares
  • Growth Stocks
  • ASX Stocks to Buy
  • Stock Research Reports
  • ASX Research Reports
  • Equity Funds
  • Hide Popular Searches